Bora Group to Acquire MacroGenics' GMP Manufacturing Operations for $122.5M
Securing Maryland-Based Drug-Substance Facility and Existing Commercial Orders to Scale the Group's Integrated Technology Platform
HONG KONG SAR - Media OutReach Newswire – 12 May 2026 - Bora Pharmaceuticals ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced that its Board of Directors has approved the acquisition of the GMP manufacturing operations, including the CDMO business, of MacroGenics, Inc.Read more: Bora Group to Acquire MacroGenics' GMP Manufacturing Operations for $122.5M


















